Faculty

05/2016–Present Beijing Tsinghua Changgung Hospital, Director of Hepatobiliary Interventional Department

05/2008–05/2016 Dalian University, Director of Clinical Translational Research Center for Biotherapy

· Director of Interventional Therapy Department (Ward + Catheterization Lab), Affiliated Zhongshan Hospital of Dalian University

· Party Branch Secretary of Pharmacology and Physicochemistry, Affiliated Zhongshan Hospital of Dalian University

04/2004–05/2008 Dalian Friendship Hospital, Director of Interventional Department (Ward + Catheterization Lab)

07/2000–05/2008 Dalian Friendship Hospital, Interventional Radiology Department, Attending Physician → Chief Physician

10/1995–09/1996 The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Neurosurgery, Resident Physician

07/1993–10/1994 The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Radiotherapy Department, Resident Physician

1. Clinical and basic research on the impact of various local therapies (including particle TACE, HAIC, and ablation) on the tumor immune microenvironment.

2. Clinical and basic research on TACE/HAIC downstaging or conversion therapy followed by surgical resection or liver transplantation for hepatobiliary tumors.

3. Clinical and basic research on optimal timing and sequencing of TACE/HAIC combined with immunotherapy/targeted drugs/cellular biotherapy (e.g., gene therapy) for hepatobiliary tumors.

4. Clinical research on optimizing techniques (e.g., PVE, PTBD/biliary stenting) in the perioperative MDT treatment of hepatobiliary tumors.

5. Clinical research on TACE/HAIC for unresectable cholangiocarcinoma.

6. Clinical research on minimally invasive techniques for other solid tumors (especially those with complications like hemorrhage), tumor reduction, microenvironment modulation, and combination with targeted/immunotherapy.

12/2024–12/2029 China Health Promotion Foundation, Gene Diagnosis and Treatment Expert Committee, Vice Chair

08/2023–07/2026 Beijing Medical Association, 3rd Interventional Medicine Branch, Vice Chair

08/2024–07/2028 Beijing Integrated Medicine Association, Health Science Popularization Expert Committee, Vice Chair

08/2022–07/2027 Beijing Cancer Prevention and Treatment Society, Minimally Invasive Interventional Therapy Committee for Liver Cancer, Vice Chair

07/2023–06/2026 National Quality Control Center for Comprehensive Interventional Technology, Committee Member

04/2022–03/2025 Chinese Medical Association, Radiology Branch, Interventional Group, Committee Member

12/2021–11/2024 Chinese Anti-Cancer Association, 5th Tumor Interventional Therapy Committee, Standing Committee Member

01/2022–12/2024 Chinese Anti-Cancer Association, 5th Tumor Minimally Invasive Therapy Committee, Standing Committee Member

08/2019–08/2022 Beijing Medical Association, Interventional Medicine Branch, Standing Committee Member

08/2019–07/2024 China Interventional Medicine Industry Technology Innovation Alliance, Executive Director

08/2019–07/2024 Shenzhen Duote Interventional Medicine Research Institute, Innovation Center for Tumor Chemoembolization, Vice Chair